CD4 and neoplasm: In an ovarian cancer model, co-administration of a PD-L1 antagonist with α4-1BB and a cellular vaccine expressing GM-CSF (GVAX) let to increases in both CD4 effector and CD8 T cell infiltrates into the tumor with a concomitant decrease in regulatory T cells (185).